What's in Clarus Therapeutics, Inc.'s pipeline?

Clarus Therapeutics, Inc. has 3 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Clarus Therapeutics, Inc.'s portfolio?

Top competitors by shared drug class: Acerus Pharmaceuticals Corporation, Acrux DDS Pty Ltd, Allergan, Alliance for Clinical Trials in Oncology, Bayer.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/clarus-therapeutics-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Clarus Therapeutics, Inc. — Portfolio Competitive Intelligence Brief

Clarus Therapeutics, Inc. pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
topical testosterone gel	topical testosterone gel	marketed	Androgen replacement therapy	Androgen receptor	Endocrinology
Axiron Testosterone Topical Solution	Axiron Testosterone Topical Solution	phase 3	Testosterone replacement therapy (TRT)	Androgen receptor	Endocrinology
Oral Testosterone Undecanoate	Oral Testosterone Undecanoate	phase 3	Androgen replacement therapy	Androgen receptor	Endocrinology

Therapeutic area mix

Endocrinology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Acerus Pharmaceuticals Corporation · 1 shared drug class
Acrux DDS Pty Ltd · 1 shared drug class
Allergan · 1 shared drug class
Alliance for Clinical Trials in Oncology · 1 shared drug class
Bayer · 1 shared drug class
Beersheva Mental Health Center · 1 shared drug class
Imperial College Healthcare NHS Trust · 1 shared drug class
Abbott · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Clarus Therapeutics, Inc.:

Cite this brief

Drug Landscape (2026). Clarus Therapeutics, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/clarus-therapeutics-inc. Accessed 2026-05-16.